The future !Well guys I just read a versant report citing $ 2.20 target for the stock.
It looks like the milestone that everyone is looking for is
1. An IND for phase 3
2. partnership with major pharma for a North American deal.
many believe that they dont have enough financing to go to phase 3 by them selfs.
I am sure they have a lot of interest by big pharma by now.
I myself dont want to be diluted again. So for all shareholders give the company a call and tell them to get a deal done.
I believe its in the best interests of the share holders now.
BB